Looking Into Bristol-Myers Squibb's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Bristol-Myers Squibb (NYSE:BMY) has seen a decrease in short interest, with the short percent of float falling 11.19% since the last report. The company has 24.10 million shares sold short, which is 1.19% of all shares available for trading. The current short interest is lower than the peer group average of 3.62%. While a decrease in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term rise in stock price.
January 05, 2024 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bristol-Myers Squibb's short interest has decreased, which may suggest a more bullish market sentiment towards the stock. However, this does not guarantee an immediate increase in stock price.
A decrease in short interest typically indicates that investors are less bearish on a stock, which could lead to a potential increase in its price. However, short interest is just one of many factors that can affect stock prices, and the article does not provide any other specific reasons to expect an immediate price change for BMY.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 80